Ticker
BFRICompany Name
BIOFRONTERA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -15.35M | $ -1.64 | 1 | 9.35M |
3/31/2025 | $ -9.71M | $ -1.09 | 1 | 8.87M |
12/31/2024 | $ -14.55M | $ -2.64 | 1 | 5.52M |
9/30/2024 | $ -9.39M | $ -1.63 | 1 | 5.77M |
6/30/2024 | $ -9.97M | $ -1.96 | 1 | 5.09M |
3/31/2024 | $ -20.14M | $ -5.56 | 1 | 3.62M |
12/31/2023 | $ -18.59M | $ -12.02 | 1 | 1.55M |
9/30/2023 | $ -24.58M | $ -17.99 | 1 | 1.37M |
6/30/2023 | $ -20.98M | $ -15.42 | 1 | 1.36M |
3/31/2023 | $ -12.17M | $ -9.11 | 1 | 1.33M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for BIOFRONTERA INC is calculated as follows: EBITDA [ $ -8.04M ] / (Shares WA [ 400K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -20.09 ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -11.29 |
max | $ 13.99 |
average | $ 2.02 |
median | $ 0.99 |
std | $ 4.27 |